These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9524673)

  • 1. [Therapy with large doses of methylprednisolone in Basedow's ophthalmopathy].
    Zbranca E; Mogoş V; Nisfoeanu G; Vulpoi C; Gneazdovschi V; Georgescu D
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):151-3. PubMed ID: 9524673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy.
    Matejka G; Vergès B; Vaillant G; Petit JM; Brun-Pacaud A; Rudoni S; Brun JM
    Horm Metab Res; 1998 Feb; 30(2):93-8. PubMed ID: 9543692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
    Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M
    Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
    Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
    Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study.
    van Geest RJ; Sasim IV; Koppeschaar HP; Kalmann R; Stravers SN; Bijlsma WR; Mourits MP
    Eur J Endocrinol; 2008 Feb; 158(2):229-37. PubMed ID: 18230831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
    Lacka K; Manuszewska E; Korczowska I; Lacki JK
    Curr Eye Res; 2007 Mar; 32(3):291-7. PubMed ID: 17453949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Shih SR; Li HY; Hsiao YL; Chang TC
    Acta Ophthalmol; 2010 Aug; 88(5):e154-9. PubMed ID: 20553230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Basedow's ophthalmopathy: a comparative evaluation of systemic or retrobulbar administration of corticosteroids associated with orbital radiotherapy].
    Pinchera A; Bartalena L; Marcocci C; Panicucci M; Gianchecchi D; Cavallacci G; Lepri A; Della Maggiora S; Marconcini C; Laddaga M
    Ann Ital Med Int; 1988; 3(1):19-25. PubMed ID: 3152833
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect of methylprednisolone pulse therapy in patients with Graves' ophthalmopathy.
    Chang TC; Hsiao YL; Liao SL
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):45-9. PubMed ID: 17653750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid therapy for Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Rinsho; 2006 Dec; 64(12):2279-85. PubMed ID: 17154092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.
    Moleti M; Giuffrida G; Sturniolo G; Squadrito G; Campennì A; Morelli S; Puxeddu E; Sisti E; Trimarchi F; Vermiglio F; Marinò M
    Endocrine; 2016 Oct; 54(1):259-268. PubMed ID: 27003434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy?
    Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I
    Med Sci Monit; 2002 Sep; 8(9):MT159-62. PubMed ID: 12218953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.
    Macchia PE; Bagattini M; Lupoli G; Vitale M; Vitale G; Fenzi G
    J Endocrinol Invest; 2001 Mar; 24(3):152-8. PubMed ID: 11314743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University].
    Kulig G; Kaźmierczyk-Puchalska A; Krzyzanowska-Swiniarska B; Pilarska K
    Przegl Lek; 2004; 61(8):852-4. PubMed ID: 15789915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Gao G; Dai J; Qian Y; Ma F
    Clin Exp Ophthalmol; 2014 Nov; 42(8):769-77. PubMed ID: 24617953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking was associated with poor response to intravenous steroids therapy in Graves' ophthalmopathy.
    Xing L; Ye L; Zhu W; Shen L; Huang F; Jiao Q; Zhou X; Wang S; Wang W; Ning G
    Br J Ophthalmol; 2015 Dec; 99(12):1686-91. PubMed ID: 26061160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.